Page last updated: 2024-11-03

procarbazine and Emphysema, Mediastinal

procarbazine has been researched along with Emphysema, Mediastinal in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research Excerpts

ExcerptRelevanceReference
"Localized pneumonitis and fibrosis are well-known sequelae of this treatment."1.27Unusual thoracic radiographic findings in children treated for Hodgkin's disease. ( Jochelson, MS; Tarbell, NJ; Weinstein, HJ, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jochelson, MS1
Tarbell, NJ1
Weinstein, HJ1

Other Studies

1 other study available for procarbazine and Emphysema, Mediastinal

ArticleYear
Unusual thoracic radiographic findings in children treated for Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

1986